{
  "3c0e4614fe9fc45936749d12d29bb127": "Prostate: Benign prostatic tissue with focal atrophy.\nProstate: No malignancy identified.\nProstate: Prostatic adenocarcinoma, gleason score 3+3=6, involving 10% of the tissue.\nProstate: No perineural invasion identified.\nProstate: No lymphvascular invasion identified.\nProstate: No extraprostatic extension identified.\nProstate: No seminal vesicle invasion identified.\nProstate: No treatment effect identified.\nProstate: No carcinoma in situ identified.\nProstate: No basal cell hyperplasia identified.\nProstate: No atrophy identified.\nProstate: No chronic inflammation identified.\nProstate: No metaplastic adenocarcinoma identified.\nProstate: No neuroendocrine tumor identified.\nProstate: No lymphoma identified.\nProstate: No melanoma identified.\nProstate: No sarcoma identified.\nProstate: No germ cell neoplasia identified.\nProstate: No papillary cystadenoma identified.\nProstate: No papillary transitional cell carcinoma identified.\nProstate: No clear cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\nProstate: No adenocarcinoma identified.\nProstate: No basal cell carcinoma identified.\nProstate: No squamous cell carcinoma identified.\n",
  "771b4d1f002ddd740017d6e4371df8d0": "Prostate:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Benign prostatic tissue with focal atrophy.\n- No evidence of malignancy.\n\nProstate, biopsy:\n- Ben",
  "BRACS_1003672": "breast mass: fibroadenoma.",
  "BRACS_1274": "breast tissue with benign mammary glands and ducts. no significant microscopic abnormalities identified.",
  "BRACS_1638": "Breast tissue with extensive intraductal and stromal fibrosis.\n- No malignancy identified.\n- Benign lymph node.\n- Other findings:\n- Ductal hyperplasia.\n- Cystic changes.\n- Apocrine metaplasia.\n- Periductal and perilobular chronic inflammation.\n- Intraluminal microcalcifications.\n- Foreign body giant cell reaction.\n- Fat necrosis.\n- Atypical ductal hyperplasia.\n- Usual ductal hyperplasia.\n- Fibrocystic changes.\n- Benign breast tissue.\n- Benign lymph node.\n- Benign skin.\n- Benign adipose tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue.\n- Benign breast tissue",
  "BRACS_1823": "breast mass: tumor type: infiltrating ductal carcinoma.\n tumor grade (bsr): moderately differentiated (bsr 6/9).\n tubule formation: 3/3.\n nuclear grade: 2/3.\n mitotic activity: 1/3.\n angiolymphatic invasion: not identified.\n microcalcifications: present.\n skin/nipple involvement: not identified.\n additional findings: fibrocystic changes.",
  "BRACS_1968": "breast tissue with benign mammary ducts and lobules. no significant microscopic abnormalities identified.",
  "BRACS_1980": "breast tissue with benign intraductal papilloma.\n - benign breast tissue with stromal fibrosis.\n - benign skin with dermal fibrosis.\n - unremarkable nipple.\n - no significant lymphadenopathy.\n - no malignancy identified.\n - biopsy site changes.\n - microcalcifications identified.\n - unremarkable skin.\n - unremarkable areola.\n - unremarkable subareolar tissue.\n - unremarkable muscle.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n - unremarkable skeletal muscle.\n - unremarkable adipose tissue.\n - unremarkable lymph node.\n - unremarkable fat.\n - unremarkable ducts.\n - unremarkable lobules.\n - unremarkable epidermis.\n - unremarkable connective tissue.\n - unremarkable vessels.\n - unremarkable nerves.\n",
  "C3L-00004-21": "Renal mass:\n- Histologic type: Clear cell renal cell carcinoma.\n- Tumor focality: Multicentric.\n- Histologic grade: Fuhrman grade 3.\n- Extracapsular extension: Not identified.\n- Vascular invasion: Not identified.\n- Lymphovascular invasion: Not identified.\n- Perinephric fat invasion: Not identified.\n- Other: No additional findings.\n- Additional findings: None.\n\nAdditional findings:\n- None.\n\nDiagnosis:\n- Clear cell renal cell carcinoma, multifocal, fuhrman grade 3.\n- No evidence of metastasis.\n- No additional findings.",
  "C3L-00088-22": "Kidney, nephrectomy : Renal cell carcinoma.\n histologic type: clear cell.\n histologic grade: fuhrman grade 3.\n extent of tumor: extends into perirenal fat.\n adrenal gland: not identified.\n additional findings: none.\n pathologic staging: pt2a nx mx.\n ajcc stage: pt2a nx mx.\n diagnosis: renal cell carcinoma, fuhrman grade 3, extending into perirenal fat.",
  "C3L-00356-22": "ovary and fallopian tube, hysterectomy : serous carcinoma.\n - fallopian tube: negative for carcinoma.\n - ovary: negative for carcinoma.\n - cervix: negative for carcinoma.\n - uterus: negative for carcinoma.\n - parametrium: negative for carcinoma.\n - additional findings: fallopian tube with benign paratubal cyst.",
  "C3L-00369-23": "Renal mass:\n- Biopsy: Renal cell carcinoma, clear cell type.\n- Fuhrman grade: Grade 3.\n- Tumor size: 2.5 cm.\n- Extracapsular extension: Not identified.\n- Lymphovascular invasion: Not identified.\n- Perinephric fat: Not involved.\n- Renal vein: Not involved.\n- Adrenal gland: Not involved.\n- Other: None.\n- Diagnosis: Renal cell carcinoma, clear cell type, grade 3.",
  "C3L-00401-22": "histologic type: high grade carcinoma.\ntumor location: breast.\n tumor size: t3.\n skin/nipple involvement: not identified.\n tumor grade (bsr): 8/9.\n angiolymphatic invasion: present.\n microcalcifications: present.\n other: extensive fibrosis.",
  "C3L-00528-21": "brain, lobe, biopsy : glioblastoma multiforme (who grade iv).\n - perivascular pseudorosettes identified.\n - idh1 mutation status: pending molecular testing.\n - idh3 mutation status: pending molecular testing.\n - ki-67 labeling index: pending.\n -.",
  "C3L-00604-26": "Lung, wedge biopsy : benign lung tissue with chronic inflammation and focal fibrosis. No malignancy identified.",
  "C3L-00907-23": "Kidney, nephrectomy : Renal cell carcinoma.\n histologic type: clear cell.\n histologic grade: fuhrman grade 3.\n extent of tumor: extends into perirenal fat.\n adrenal gland: not involved.\n additional findings: none.\n pathologic staging: pt2a nx mx.\n ajcc stage: pt2a nx mx.\n diagnosis: renal cell carcinoma, fuhrman grade 3, extending into perirenal fat.",
  "C3L-00987-27": "Muscle, thigh, biopsy:\n - No significant pathologic abnormality.",
  "C3L-01355-22": "lung, lobe, wedge biopsy : consistent with metastatic colorectal adenocarcinoma.",
  "C3L-01836-26": "Kidney, nephrectomy : Renal cell carcinoma.\n histologic type: clear cell.\n histologic grade: fuhrman grade 2.\n extent of tumor: limited to the kidney.\n additional findings: none.\n pathologic staging: pt1.",
  "C3L-01955-22": "Kidney, nephrectomy : Renal cell carcinoma.\n histologic type: clear cell.\n histologic grade: fuhrman grade 2.\n extent of tumor: limited to the kidney.\n additional findings: none.",
  "C3L-02125-27": "breast, core biopsy : tumor type: infiltrating ductal carcinoma.\n tumor grade (bsr): 8/9, poorly differentiated.\n tubule formation: 3/3.\n nuclear grade: 3/3.\n mitotic activity: 2/3.\n angiolymphatic invasion: not identified.\n microcalcifications: not identified.",
  "C3L-02204-21": "Liver biopsy:\n - Chronic hepatitis C with moderate necroinflammatory activity.\n - Portal fibrosis with bridging fibrosis.\n - No hepatocellular carcinoma identified.\n - Special stains for Hep C viral antigen are negative.\n - No evidence of steatohepatitis.\n - No evidence of cirrhosis.\n - No evidence of hepatocellular carcinoma.\n - No evidence of cholangiocarcinoma.\n - No evidence of metastatic disease.\n - No evidence of granulomatous disease.\n - No evidence of fungal or mycobacterial infection.\n - No evidence of drug-induced liver injury.\n - No evidence of autoimmune hepatitis.\n - No evidence of primary biliary cholangitis.\n - No evidence of primary sclerosing cholangitis.\n - No evidence of Wilson disease.\n - No evidence of alpha-1 antitrypsin deficiency.\n - No evidence of hemochromatosis.\n - No evidence of non-alcoholic fatty liver disease.\n - No evidence of non-alcoholic steatohepatitis.\n - No evidence of autoimmune hepatitis.\n - No evidence of primary biliary cholangitis.\n - No evidence of primary sclerosing cholangitis.\n - No evidence of Wilson disease.\n - No evidence of alpha-1 antitrypsin deficiency.\n - No evidence of hemochromatosis.\n - No evidence of non-alcoholic fatty liver disease.\n - No evidence of non-alcoholic steatohepatitis.\n - No evidence of autoimmune hepatitis.\n - No evidence of primary biliary cholangitis.\n - No evidence of primary sclerosing cholangitis.\n - No evidence of Wilson disease.\n - No evidence of alpha-1 antitrypsin deficiency.\n - No evidence of hemochromatosis.\n - No evidence of non-alcoholic fatty liver disease.\n - No evidence of non-alcoholic steatohepatitis.\n - No evidence of autoimmune hepatitis.\n - No evidence of primary biliary cholangitis.\n - No evidence of primary sclerosing cholangitis.\n - No evidence of Wilson disease.\n - No evidence of alpha-1 antitrypsin deficiency.\n - No evidence of hemochromatosis.\n - No evidence of non-alcoholic fatty liver disease.\n - No evidence of non-alcoholic steatohepatitis.\n - No evidence of autoimmune hepatitis.\n - No evidence of primary biliary cholangitis.\n - No evidence of primary sclerosing cholangitis.\n - No evidence of Wilson disease.\n - No evidence of alpha-1 antitrypsin deficiency.\n - No",
  "C3L-02349-21": "breast, core biopsy : tumor type: infiltrating ductal carcinoma.\n tumor grade (bsr): moderately differentiated (bsr 6/9).\n tubule formation: 3/3\n nuclear grade: 2/3\n mitotic activity: 1/3\n angiolymphatic invasion: not identified.\n microcalcifications: not identified.",
  "C3L-02389-22": "fibrous tissue with spindle cells.",
  "C3L-02463-24": "Stomach, biopsy: Gastric mucosa with no significant pathologic abnormality.\n - No H. pylori identified.\n - No dysplasia identified.\n - No carcinoma identified.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor.\n - No evidence of chronic gastritis.\n - No evidence of acute gastritis.\n - No evidence of peptic ulcer.\n - No evidence of intestinal metaplasia.\n - No evidence of gastric lymphoma.\n - No evidence of gastric carcinoid tumor.\n - No evidence of gastrointestinal stromal tumor",
  "C3L-02613-21": "biopsy: tumor present.",
  "C3L-02619-26": "Pulmonary lobectomy specimen.\n - Lung with chronic interstitial lung disease.\n - No evidence of malignancy.\n - One benign lymph node.\n - No evidence of metastatic disease.\n - No evidence of infection.\n - Pleura with no significant pathological diagnosis.\n - Artery with no significant pathological diagnosis.\n - Vein with no significant pathological diagnosis.\n - Nerves with no significant pathological diagnosis.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic inflammation.\n - Small focus of fibrosis with chronic",
  "C3L-02642-25": "histologic type: high grade carcinoma.\ntumor location: breast.\n tumor size: t3n1m0.\n skin/nipple involvement: not identified.\n additional findings: biopsy site changes.",
  "C3L-02706-24": "FINDINGS: The image shows a section of liver with extensive necrosis and inflammation. There is a prominent inflammatory infiltrate. The architecture is disrupted.\n\nIMPRESSION: Liver necrosis and inflammation.",
  "C3L-02957-23": "lung, lobe, wedge biopsy : consistent with metastatic carcinoma.",
  "C3L-02970-21": "FINDINGS: The specimen is a soft tissue mass. The mass is composed of blood and necrotic debris. There is no identifiable tissue architecture.\n\nIMPRESSION: Soft tissue mass composed of blood and necrotic debris. No identifiable tissue architecture.",
  "C3L-03143-21": "ovarian serous cystadenocarcinoma.",
  "C3L-03372-24": "biopsy: diffuse large b-cell lymphoma.",
  "C3L-03378-24": "breast, stereotactic core biopsy : tumor type: infiltrating ductal carcinoma.\n tumor grade (bsr): 7/9, moderately differentiated.\n tubule formation: 3/3.\n nuclear grade: 2/3.\n mitotic activity: 2/3.\n angiolymphatic invasion: not identified.\n microcalcifications: present.\n skin/nipple involvement: not identified.\n additional findings: biopsy site changes.",
  "C3L-03969-25": "pancreatic adenocarcinoma.\n tumor focality: unifocal.\n histologic grade: moderately differentiated.\n tumor border: infiltrative.\n angiolymphatic invasion: identified.\n perineural invasion: identified.\n additional findings: chronic pancreatitis.",
  "C3L-03985-25": "lung, lobe, biopsy : consistent with metastatic adenocarcinoma.",
  "C3L-04404-21": "skin, shave biopsy : basal cell carcinoma extending to the base of the biopsy.",
  "C3L-04473-24": "pancreas:\n - fatty infiltration.\n - no mass or focal lesion.\n - pancreatic duct is not dilated.\n - no significant peripancreatic inflammation.\n - spleen: unremarkable.\n - adrenal glands: unremarkable.\n - liver: unremarkable.\n - kidneys: unremarkable.\n - small bowel: unremarkable.\n - colon: unremarkable.\n - appendix: unremarkable.\n - lymph nodes: unremarkable.\n - peritoneal cavity: no ascites or implant.\n - skeletal: no significant abnormality.\n - other: none.",
  "C3N-01714-21": "histologic type: fibroadenoma.\n histologic grade: well differentiated.\n necrosis: none.\n microcalcifications: none identified.\n additional findings: none.\n impression: fibroadenoma.",
  "C3N-01806-21": "lung, lobe, wedge biopsy : lung adenocarcinoma, moderately differentiated.\n - positive surgical margin.\n - negative margin.\n - negative margin.\n - tumor focality: unifocal.\n - visceral pleural invasion: not identified.\n - tumor associated atelectasis or obstructive pneumonitis: not present.\n - lymph-vascular invasion: not identified.\n - perineural invasion: not identified.\n - additional findings: none.",
  "C3N-01879-21": "Lung, lobe, wedge biopsy:\n - Biopsy site changes with chronic inflammation.\n - No malignancy identified.\n - Negative for fungal organisms.\n - Negative for acid fast bacilli.\n\nAdditional findings:\n - Small foci of necrosis.\n - Respiratory bronchiolitis.\n - Emphysematous changes.\n - Interstitial fibrosis.\n\nDiagnosis:\n - Biopsy site changes with chronic inflammation.\n - No malignancy identified.\n - Negative for fungal organisms.\n - Negative for acid fast bacilli.\n - Small foci of necrosis.\n - Respiratory bronchiolitis.\n - Emphysematous changes.\n - Interstitial fibrosis.",
  "C3N-02763-21": "renal mass : angiomyolipoma.",
  "C3N-03011-24": "lung, lobe, wedge biopsy : consistent with metastatic carcinoma.",
  "C3N-03054-22": "lung, lobe, wedge biopsy : consistent with metastatic carcinoma.\n -small focus of necrosis.\n -one benign lymph node.\n -no evidence of extramural tumor.\n -no definitive evidence of squamous differentiation.\n -no definitive evidence of adenocarcinoma.\n -no definitive evidence of neuroendocrine tumor.\n -no definitive evidence of melanoma.\n -no definitive evidence of sarcoma.\n -no definitive evidence of lymphoma.\n -no definitive evidence of leukemia.\n -no definitive evidence of fungal infection.\n -no definitive evidence of bacterial infection.\n -no definitive evidence of viral infection.\n -no definitive evidence of foreign body.\n -no definitive evidence of eosinophilic pneumonia.\n -no definitive evidence of acute interstitial pneumonia.\n -no definitive evidence of organizing pneumonia.\n -no definitive evidence of diffuse alveolar damage.\n -no definitive evidence of pulmonary edema.\n -no definitive evidence of pulmonary hemorrhage.\n -no definitive evidence of pulmonary alveolar proteinosis.\n -no definitive evidence of idiopathic pulmonary fibrosis.\n -no definitive evidence of asbestosis.\n -no definitive evidence of silicosis.\n -no definitive evidence of sarcoidosis.\n -no definitive evidence of hypersensitivity pneumonitis.\n -no definitive evidence of malignancy.\n -no definitive evidence of infection.\n -no definitive evidence of inflammation.\n -no definitive evidence of drug reaction.\n -no definitive evidence of vascular abnormality.\n -no definitive evidence of cardiac abnormality.\n -no definitive evidence of renal abnormality.\n -no definitive evidence of hepatic abnormality.\n -no definitive evidence of gastrointestinal abnormality.\n -no definitive evidence of skeletal abnormality.\n -no definitive evidence of dermatologic abnormality.\n -no definitive evidence of neurologic abnormality.\n -no definitive evidence of ocular abnormality.\n -no definitive evidence of otologic abnormality.\n -no definitive evidence of mastoid abnormality.\n -no definitive evidence of salivary gland abnormality.\n -no definitive evidence of thyroid abnormality.\n -no definitive evidence of parotid gland abnormality.\n -no definitive evidence of submandibular gland abnormality.\n -no definitive evidence of lacrimal gland abnormality.\n -no definitive evidence of orbital abnormality.\n -no definitive evidence of nasal cavity abnormality.\n -no definitive evidence of paranasal sinus abnormality.\n -no definitive evidence of oral cavity abnormality.\n -no definitive evidence of pharyngeal abnormality.\n -no definitive evidence of laryngeal abnormality.\n -no definitive evidence of tracheal abnormality.\n -",
  "C3N-03186-23": "histologic type: poorly differentiated carcinoma.\ntumor location: breast.\n tumor grade: grade 3.\n tubule formation: 3.\n nuclear grade: 3.\n mitotic activity: 3.\n angiolymphatic invasion: not identified.\n microcalcifications: not identified.",
  "C3N-03226-21": "skin, punch biopsy : squamous cell carcinoma, extending to the lateral margin.\n - biopsy site changes.\n - no evidence of metastasis.",
  "C3N-03458-21": "skin, punch biopsy : squamous cell carcinoma, extending to the lateral margin.\n - biopsy site changes.\n - no evidence of metastasis.",
  "C3N-03849-22": "histologic type: poorly differentiated carcinoma.\ntumor location: lung.\n histologic grade: grade 3.\n visceral pleura: not involved.\n angiolymphatic invasion: present.\n perineural invasion: not identified.",
  "a295d73e91c9f8d8d16a8c1a3469714a": "Prostate:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- Benign prostatic",
  "bedeb6cf82f3257a34cfdad3dba80413": "histologic type: leiomyosarcoma\n histologic grade: high grade\n tumor configuration: nodular\n angiolymphatic invasion: present\n perineural invasion: present\n additional findings: none\n\n tumor size: 1.5 x 1.0 x",
  "c9bcd1d4867a43cec02af7f3b555709f": "prostate: benign prostatic tissue with focal atrophy.",
  "e19325ebb64adc3293f7173d7a337409": "Prostate:\n- Benign prostatic tissue with focal atrophy.\n- No malignancy identified.\n\nProstate, TURP specimen:\n- No malignancy identified.\n- Prostatic tissue with chronic inflammation.\n- Seminal vesicles with chronic inflammation.\n- Urinary bladder with chronic inflammation.\n- Urethra with chronic inflammation.\n- Peripheral nerve bundles with chronic inflammation.\n- Lymph nodes with chronic inflammation.\n\nComments:\n- No malignancy identified.\n- The specimen is consistent with a TURP procedure.\n- The prostate gland is moderately enlarged.\n- The seminal vesicles and urinary bladder are unremarkable.\n- The peripheral nerve bundles are unremarkable.\n- The lymph nodes are unremarkable.\n- The urinary tract mucosa is unremarkable.\n- The specimen is fixed and processed in standard fashion.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen.\n- The sections examined are representative of the entire specimen."
}